Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Hidehisa Tachiki"'
Autor:
Takashi Tomita, Akiko Yamaguchi, Naoe Nishimura, Hidekazu Goto, Kenji Sumiya, Ryo Arakawa, Tadashi Yoshida, Hidehisa Tachiki, Yukinao Kohda, Kenzo Kudo
Publikováno v:
Heliyon, Vol 5, Iss 11, Pp e02764- (2019)
This study was designed to determine the effects of a food thickener and deglutition aid jelly for oral administration, jelly wafer, on the pharmacokinetics of levofloxacin orally disintegrating tablets. With an increase in immersion time, the disint
Externí odkaz:
https://doaj.org/article/7ae45125e6bb40bc9fd362adbec19ec8
Autor:
Hitoshi Uchiyama, Masayuki Tsujimoto, Tadakazu Shinmoto, Hitomi Ogino, Tomoko Oda, Takuya Yoshida, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Hidehisa Tachiki, Tetsuya Minegaki, Kohshi Nishiguchi
Publikováno v:
Toxins, Vol 6, Iss 9, Pp 2612-2625 (2014)
The risk of myopathy and rhabdomyolysis is considerably increased in statin users with end-stage renal failure (ESRF). Uremic toxins, which accumulate in patients with ESRF, exert cytotoxic effects that are mediated by various mechanisms. Therefore,
Externí odkaz:
https://doaj.org/article/3a6e0beb54f44a2c98f93829b110fd0d
Autor:
Hitoshi Uchiyama, Masayuki Tsujimoto, Naomi Shimada, Koji Tsutsui, Ayaka Nitta, Takuya Yoshida, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Hidehisa Tachiki, Tetsuya Minegaki, Kohshi Nishiguchi
Publikováno v:
Toxins, Vol 10, Iss 2, p 53 (2018)
Patients with end-stage kidney disease (ESKD) are at higher risk for rhabdomyolysis induced by statin than patients with normal kidney function. Previously, we showed that this increase in the severity of statin-induced rhabdomyolysis was partly due
Externí odkaz:
https://doaj.org/article/05f46d0ead054cedabfaf0ff7c448144
Autor:
Rika Ishikawa, Kosuke Saito, Hidehisa Tachiki, Ryoya Goda, Koji Arai, Hisao Shimizu, Tomohiro Andou, Kentaro Takahara, Hitoshi Uchiyama, Shin-ichiro Nitta, Masaaki Kakehi, Kozo Hayashi, Naohiro Katagiri, Keiko Kojima, Hisashi Fujita, Kazuhiro Tsuchinaga, Yoshiro Saito
Publikováno v:
Bioanalysis. 15:207-218
Background: Although the fit-for-purpose approach has been proposed for biomarker assay validation, practical data should be compiled to facilitate the predetermination of acceptance criteria. Methods: Immunoaffinity LC–MS was used to analyze gluca
Autor:
Hiroyuki Sawada, Nobue Terakawa, Naoe Nishimura, Akihito Kogure, Hidehisa Tachiki, Akira Oita
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 47:70-80
Autor:
Noriko Inoue, Takuma Shigeyama, Hidehisa Tachiki, Takeru Yamaguchi, Kazuyuki Murata, Koji Arai, Shinichi Yamane, Mitsuhiko Kawabata, Mariko Yamaoka, Mio Nakatsuji, Takeshi Okuzono, Noritaka Hashii, Yoshiro Saito, Suguru Fukuda, Akiko Ishii-Watabe, Yoshimasa Enoki, Yoshiko Tousaka, Ryoya Goda
Publikováno v:
Bioanalysis. 13:265-276
Aim: We aimed to develop an easy, low-cost and versatile mass spectrometric method for the bioanalysis of a therapeutic monoclonal antibody (mAb) in human serum that employs peptide adsorption-controlled (PAC)-LC/MS using selected reaction monitoring
Autor:
Takeshi Okuzono, Hidehisa Tachiki, Noritaka Hashii, Koji Arai, Shinichi Yamane, Ryoya Goda, Yoshiro Saito, Yoshiko Tousaka, Akiko Ishii-Watabe, Takuma Shigeyama, Kazuyuki Murata, Satomi Sasahara, Noriko Inoue
Publikováno v:
Bioanalysis. 12:231-243
Aim: A generic bioanalytical method was developed to quantify therapeutic IgG1 monoclonal antibodies (mAbs) in mouse sera by combining an easy sample preparation method with LC/MS using selected reaction monitoring. Materials & methods: Rituximab and
Autor:
Kenta Mizoi, Misako Kobayashi, Arisa Mashimo, Eiko Matsumoto, Norio Masuda, Manabu Itoh, Toshiya Ueno, Hidehisa Tachiki, Seiichi Ishida, Takuo Ogihara
Publikováno v:
Biologicalpharmaceutical bulletin. 45(1)
The aim of this work is to develop a new assay system for screening biliary excretion drugs. When monolayers of human liver-derived cell lines HepG2 and Huh-7 were grown on an insert membrane, the efflux ratio (ER: ratio of the apparent permeability
Autor:
Tsuyoshi Matsumura, Kota Asahina, Mariko Yamaoka, Mitsuhiko Kawabata, Rika Ishikawa, Saki Yamauchi, Takahiro Suga, Shin-Ichiro Nitta, Akemi Nagao, Yoshiro Saito, Hitoshi Uchiyama, Keiko Nakai, Koji Arai, Ryoya Goda, Kosuke Saito, Hidehisa Tachiki
Publikováno v:
Bioanalysis. 13(20)
Aim: Although the fit-for-purpose approach has been proposed for validation procedures and acceptance criteria for biomarker assays, practical biomarker assays to facilitate clinical application and regulatory documents on biomarker assays remain lim
Autor:
Norihiro Sakai, Kenya Kamimura, Hirotaka Miyamoto, Masayoshi Ko, Takuro Nagoya, Toru Setsu, Akira Sakamaki, Takeshi Yokoo, Hiroteru Kamimura, Hiroyuki Soki, Ayako Tokunaga, Tatsuo Inamine, Mikiro Nakashima, Hatsune Enomoto, Kazuki Kousaka, Hidehisa Tachiki, Kaname Ohyama, Shuji Terai
Publikováno v:
Journal of gastroenterology. 58(1)
To establish a treatment option for liver fibrosis, the possibility of the drug repurposing theory was investigated, with a focus on the off-target effects of active pharmaceutical ingredients.First, several active pharmaceutical ingredients were scr